Inspirata Europe Achieves ISO 9001 Certification and the Inclusion of its Cancer AI on NHS Supply Chain Frameworks
07 juil. 2021 04h00 HE
|
Inspirata, Inc.
London, United Kingdom, July 07, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that its UK subsidiary, Inspirata Europe, has achieved...
Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort
28 juin 2021 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 28, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inspirata Renews Digital Pathology Partnership with Shared Health (Province of Manitoba)
23 juin 2021 09h00 HE
|
Inspirata, Inc.
Tampa, Florida, June 23, 2021 (GLOBE NEWSWIRE) -- Digital pathology and cancer informatics provider Inspirata announced today the extension of its multi-year partnership with Shared Health, a health...
Global Cancer Diagnostics Market Report 2021-2026: Growth in the Number of Private Diagnostic Centers & Availability of Reimbursement
31 mai 2021 04h43 HE
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology...
Inspirata and Fujifilm UK Partnership Generates NHS Success with One Dorset Pathology Network Digital Pathology Engagement
19 mai 2021 04h00 HE
|
Inspirata, Inc.
London, United Kingdom, May 19, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that University Hospitals Dorset NHS Foundation Trust will...
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.
30 avr. 2021 15h40 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 30, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeScreen POL Offering by Q4-2021
26 avr. 2021 11h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers...
Inotiv, Inc. Announces Plan to Expand the Company’s Internal Operations
19 avr. 2021 07h00 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 19, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
16 avr. 2021 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research...
Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.
13 avr. 2021 16h35 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research...